Across TCGA pan-cancer cohorts, CD177 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CD177 data layer compared with 23 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher CD177 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CD177 expression acts as an unfavorable survival marker.

SKCM, GBM, and BRCA are the cancer types where CD177 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	III,IV	0.099	0.655	<.001	10	view →
GBM	DFS	Median	All	0.031	0.257	<.001	6	view →
BRCA	OS	Median	All	0.120	0.578	.045	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: CD177 tumor-vs-normal RNA expression · all CD177 data types